PRESS RELEASE
News
-
-
-
REGULATED PRESS RELEASE
NFL BIOSCIENCES: FINANCIAL CALENDAR FOR 2024
NFL Biosciences, a biopharmaceutical company, has announced its financial communication calendar for 2024, including dates for annual results, Annual General Meeting, and half-year results. The company is known for developing botanical drug candidates for the treatment of addictions, such as NFL-101 for nicotine cessation and NFL-301 for reducing alcohol consumption. For more information, visit www.nflbiosciences.com. -
REGULATED PRESS RELEASE
CHARGEURS - Voting rights monthly statement as of December 31st, 2023
CHARGEURS, a French Société Anonyme, has released its monthly statement on outstanding shares and voting rights in compliance with the French Commercial Code and the General Regulation of the Financial Markets Authority (AMF). As of December 31, 2023, the total number of shares is 24,862,314 with a gross total of voting rights at 26,219,780 and a net total of 25,395,320. This statement provides important information for shareholders and investors. -
REGULATED PRESS RELEASE
CHARGEURS - Déclaration mensuelle DDV au 31 décembre 2023
Le 9 janvier 2024, la publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote a été effectuée conformément aux articles L.233-8 du Code commerce et 223-16 du Règlement général de l’AMF. La société CHARGEURS, société anonyme au capital de 3 977 970,24 euros, a publié les informations relatives au nombre total d’actions composant le capital et le nombre total des droits de vote -
REGULATED PRESS RELEASE
RESULTATS SEMESTRIELS 2023/2024
TFF Group annonce une croissance conforme aux attentes pour le semestre 2023/2024 avec un résultat opérationnel courant supérieur à 20 % du CA. La division Alcools affiche une croissance de 25,0 % avec une progression significative de la rentabilité -
REGULATED PRESS RELEASE
Déclaration du nombre d'actions composant le capital et du nombre total de droits de vote au 31 Décembre 2023
Le nombre d'actions et de droits de vote d'Eurazeo pour l'année 2023 a été déclaré selon l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement Général de l’AMF -
REGULATED PRESS RELEASE
Disclosure of the number of shares and the total number of voting rights as of December 31, 2023
Eurazeo, a leading European investment group, has disclosed the total number of shares and voting rights as of December 31, 2023, in compliance with the French Commercial Code and the Financial Markets Authority regulations. With assets of 33.5 billion euros and a strong financial structure, Eurazeo supports over 600 mid-market companies using its sector expertise and global market access through 12 offices worldwide. The group is listed on Euronext Paris. -
PRESS RELEASE
Sordoni Construction Co. Announces It Has Gained a Project Executive
Sordoni Construction Company is thrilled to announce the promotion of Dayton Pierce from Project Director to Project Executive. With 17 years of industry experience, Dayton has a comprehensive understanding of managing and overseeing various project components both on and off the field, including entitlements, preconstruction, procurement, cost management, scheduling, and safety. His promotion is a recognition of his hard work mentality, ability to mentor his teams, and his successful track record of completing over $125 million of projects. Dayton's wide range of project experience includes life sciences, residential, corporate, commercial, and industrial, making him a valuable asset to the company. -
PRESS RELEASE
Mentavi Health Partnering with Colleges, Universities to Help Students with Mental Health Services
Mentavi Health, a leader in mental assessments, is partnering with colleges and universities to provide timely and cost-effective mental health services to students with ADHD, anxiety, and depression. By working with Mentavi Health, institutions can connect students with diagnoses and treatments, helping to support academic success. The partnership also allows colleges to maintain control over medication prescriptions and reduces out-of-pocket costs for students. Mentavi's Smart Assessment system offers easy and quick results based on clinical evaluation by licensed psychologists, addressing key concerns about medication use and diversity, equity, and inclusion considerations. Additionally, Mentavi is being used by athletic departments to document valid diagnoses and is proving to be an effective partner in holding down costs and ensuring student success.
